Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

21.34
-1.1200-4.99%
Post-market: 21.610.2700+1.27%19:59 EDT
Volume:26.40M
Turnover:569.52M
Market Cap:4.86B
PE:41.66
High:22.30
Open:22.21
Low:21.09
Close:22.46
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.86
T/O Rate:13.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:8.98
PE(LYR):41.66

Loading ...

Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements

Tiger Newspress
·
Dec 01, 2025

Moderately bullish activity in Hims and Hers Health with shares up 2.72%

TIPRANKS
·
Nov 28, 2025

Hims & Hers Health Chief Legal Officer Soleil Boughton Reports Sale of Common Shares

Reuters
·
Nov 26, 2025

Hims & Hers (HIMS) Is Up 6.2% After $250M Buyback and Labs Launch Is Growth Story Evolving?

Simply Wall St.
·
Nov 25, 2025

Mixed options sentiment in Hims and Hers Health with shares up 7.46%

TIPRANKS
·
Nov 25, 2025

Evaluating Hims & Hers Shares After 28.8% Drop and New Telehealth Partnerships

Simply Wall St.
·
Nov 24, 2025

Mixed options sentiment in Hims and Hers Health with shares down 3.65%

TIPRANKS
·
Nov 20, 2025

Hims & Hers (HIMS) Investors Keep the Faith as Stock Slides 15%

TIPRANKS
·
Nov 19, 2025

Truist Financial Sticks to Its Hold Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
Nov 18, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: NRX Pharmaceuticals (NRXP), LifeMD (LFMD) and Hims & Hers Health (HIMS)

TIPRANKS
·
Nov 18, 2025

What's Going On With Hims & Hers Health Shares Monday?

Benzinga
·
Nov 18, 2025

Hims & Hers Health Inc. Authorizes $250 Million Share Repurchase Program in USD

Reuters
·
Nov 17, 2025

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization

THOMSON REUTERS
·
Nov 17, 2025

BRIEF-Hims & Hers Names Deb Autor As Chief Policy Officer To Lead Policy And Regulatory Strategy

Reuters
·
Nov 17, 2025

Hims & Hers: Names Deb Autor as Chief Policy Officer to Lead Policy and Regulatory Strategy

THOMSON REUTERS
·
Nov 17, 2025

Hims & Hers names ex-FDA official Deb Autor as first policy chief

Reuters
·
Nov 17, 2025

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing

Benzinga_recent_news
·
Nov 15, 2025

Hims & Hers Bets on Lab Testing to Boost Growth -- Update

Dow Jones
·
Nov 14, 2025

Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform

TIPRANKS
·
Nov 14, 2025

Hims & Hers Health Launches Lab-Testing Product

MT Newswires Live
·
Nov 14, 2025